Tom Taulli

Tom Taulli

Expertise: Artificial intelligence, cloud computing, cybersecurity

Education: BA, Cal Poly Pomona; JD, Whittier Law School

Awards & Accomplishments: IRS Enrolled Agent; California insurance license

Tom Taulli is the author of various books. They include Artificial Intelligence Basics and the Robotic Process Automation Handbook. His upcoming book is called Generative AI: How ChatGPT and other AI Tools Will Revolutionize Business.

Besides his writing, Tom has authored courses for PluralSight, Apress and O’Reilly Publishing. And yes, they are about topics like AI and cloud computing.

Tom currently advises various early stage companies about AI. He also is an angel investor.

Before this, Tom founded tech companies like ExamWeb, WebIPO and Hypermart, which was sold to InfoSpace.

Recent Articles

Why the Outlook of Best Buy Stock Is Still Upbeat

After Joly resigned as BBY CEO, the outlook of BBY and of Best Buy stock remain quite strong.

3 Reasons It Is Really Easy to Be Bullish on AT&T Stock

AT&T stock has languished for a while. But this could be setting up for a value opportunity. The acquisition of Time Warner looks spot on and there should be a boost from the move to 5G.

Cannabis Company Greenlane Gets Ready for an IPO

The cannabis trade has been hot and Greenlane plans to come public this week. Here’s a look at the deal.

Is AbbVie Stock An Undiscovered Cannabis Play Waiting For Some Attention?

AbbVie stock's been fairly awful lately as its core drug is showing signs of slowing down. Yet ABBV stock should not be ignored since there’s a bit of a cannabis play here.

3 Ways AI Is Driving Growth for Amazon Stock

Amazon.com is making artificial intelligence a focus, as the company believes AI will lead to greater growth for Amazon stock.

7 Internet Stocks to Watch

In the UK, it looks like the government will impose stricter regulations on the internet, but this isn't a signal to unload internet stocks.

Pinterest IPO: What Can We Expect As Another Unicorn Comes To Market?

Pinterest plans to come public next week. The company is solid , but investors should still treat this deal as a high-risk proposition.

3 Reasons Booking Holdings Stock Will Take Flight

Booking Holdings stock has been a laggard over the past year. But this could be setting up for a value opportunity. Here's a look at 3 key bullish factors.

CVS Stock Is Not Nearly as Cheap as You Might Think

CVS stock has been mostly a losing proposition for investors since 2015. So maybe now -- with the valuation fairly low -- is a good time for a purchase? Well, investors may still want to wait.

Cronos Group: 3 Pros, 3 Cons for Buying CRON Stock on This Dip

Cronos Group is one of the top operators in the fast-growing cannabis market, but CRON stock has leveled off lately as Wall Street gets anxious. What now?